MedTrace Logo

Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, with CoViD-19

NCT04765371 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2024-09-19

No results posted yet for this study

Summary

The aim of the study is to evaluate two differents regimens of corticosteroids (prednisolone versus dexamethasone) on D28 mortality in patients with CoViD 19 pneumonia requiring oxygen supplementation

Conditions

  • Coronavirus Infection

Interventions

DRUG

DEXAMETHASONE

Patients will take 60 mg per day of Prednisolone (40 mg morning and 20 md evening) between D1 to D10

DRUG

PREDNISOLONE

Patients will take 60 mg per day of Prednisolone (40 mg morning and 20 md evening) between D1 to D10

Sponsors & Collaborators

  • Hôpital NOVO

    lead OTHER

Principal Investigators

  • Dr Edouard DEVAUD · Hôpital NOVO

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-03
Primary Completion
2022-02-10
Completion
2022-02-10

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04765371 on ClinicalTrials.gov